Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Ministry of Health
  1. Home
  2. Newsroom
  3. Rate of Healthcare-associated Infections in Healthcare Facilities
Parliamentary QA

Rate of Healthcare-associated Infections in Healthcare Facilities

10 September 2024

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

NOTICE PAPER NO. 3060

NOTICE OF QUESTION FOR ORAL ANSWER

FOR THE SITTING OF PARLIAMENT ON OR AFTER 10 SEPTEMBER 2024



Name and Constituency of Member of Parliament

Mr Ong Hua Han

Nominated MP 


Question No. 6576


To ask the Minister for Health (a) in each year of the past five years, what is the rate of healthcare-associated infections (HAIs) in healthcare facilities; (b) what has the Ministry done to reduce the rate of HAIs; (c) what are the Ministry’s targets for managing HAIs; and (d) whether the Ministry will consider publishing data reports on HAIs every few years to track progress and target weak areas.



Written Answer


1     MOH tracks healthcare-associated infections (HAIs) in acute Public Healthcare Institutions for (a) device-associated infections and (b) various multi-drug resistant organisms (MDROs) in the Intensive Care (ICU) setting.  These are the most common sources of HAIs. 


2     In the ICU setting, the rates for hospital-associated urinary tract infections and central line infections are 3.56 and 2.15 per 1,000 device-days respectively in 2019, and 2.80 and 1.51 per 1,000 device-days respectively in 2023. For ventilator-associated infections, the infection rates are 8.23 in 2019 and 11.70 in 2023.  


3     For MDROs, the prevalence rates for Methicillin-resistant Staphylococcus aureus are 0.54 per 10,000 patient-days in 2021, and 0.35 per 10,000 patient-days in 2023. In the same period, the prevalence rates for Carbapenem-resistant Enterobacteriaceae are 0.45 and 0.91 respectively. This rise in Carbapenemase-producing CRE (CP-CRE) prevalence is similar to what has been observed globally and related to antibiotic usage practice in the hospitals.


4     MOH aims to bring down HAIs to as low as possible.  Ultimately, there needs to be a strong culture of vigilance, embedded within care protocols and clinical practice. A Technical Advisory Group on CP-CRE has been convened to recommend further targeted actions to reduce Carbapenemase-producing Enterobacteriaceae infections within the next three years.

Back to top